Sentences with phrase «outcome of heart failure»

Not exact matches

Professor Voors concluded: «The major finding from this substudy of the RELAX - AHF trial is that diuretic resistance is a clinical problem that leads to worse in - hospital and early post-discharge clinical outcomes in patients with acute heart failure.

The TOPCAT trial is the first randomized, double - blind trial to assess the effect of spironolactone on clinical outcomes in these patients with heart failure and preserved ejection fraction.

A late - breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functHeart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funFailure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functHeart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functheart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funfailure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functheart failure and preserved ejection fraction (pump funfailure and preserved ejection fraction (pump function).

Researchers studied data from 2,279 heart failure patients in a trial called Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF - ACTheart failure patients in a trial called Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF - Afailure patients in a trial called Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF - ACTHeart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF - AFailure: A Controlled Trial Investigating Outcomes of Exercise Training (HF - ACTION).

RELAX - AHF was a randomised, double blind controlled trial that evaluated the effects of a 48 - hour infusion of the intravenous drug, serelaxin, on clinical outcomes in 1 161 patients admitted to hospital for acute heart failure.

Looking at the components of the primary outcome separately, only hospitalizations, specifically for heart failure, had a significantly lower incidence for those taking spironolactone compared to placebo, with 206 patients (12.0 percent) in the spironolactone group undergoing hospitalization versus 245 patients (14.2 percent) in the placebo group.

Better treatments for heart failure and new ways of predicting patient outcomes are needed, researchers concluded.

Contrary to popular practice, a measure of the heart's pumping function known as «left ventricular ejection fraction» is not associated with the long - term outcomes of hospitalized heart failure patients, a UCLA - led study of Medicare patients has found.

To investigate, Csaba Kovesdy, MD (Memphis VA Medical Center and the University of Tennessee Health Science Center) and his colleagues examined information from the national VA research database and looked for associations between blood pressure and various clinical outcomes — coronary heart disease, stroke, kidney failure, and death — in more than 300,000 patients with CKD.

The one - year outcome of in - hospital morbidity and mortality was similar between diastolic and systolic heart failure patients.

A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long - term outcomes between congestive heart failure patients with preserved ejection fraction commonly known as «diastolic heart failure» and congestive heart failure with reduced ejection fraction also known as «systolic heart failure.»

The study, appearing in the Journal of the American Heart Association, is the first to identify predictors of poor outcomes in Duchenne muscular dystrophy (DMD) patients, said senior author Dr. Pradeep Mammen, a heart failure specialist at UT Southwestern Medical CeHeart Association, is the first to identify predictors of poor outcomes in Duchenne muscular dystrophy (DMD) patients, said senior author Dr. Pradeep Mammen, a heart failure specialist at UT Southwestern Medical Ceheart failure specialist at UT Southwestern Medical Center.

However, telomere length and CPC levels are independent and additive predictors of adverse cardiovascular outcomes (such as death, heart attack, stroke, or hospitalization for heart failure), he finds.

The outcomes of this preliminary study have resulted in the implementation of larger, placebo - controlled clinical studies to assess if individuals with heart failure as well as diabetes show improvement in their exercise capacity when given epicatechin - rich cocoa.

Doukky R and others: «Impact of dietary sodium restriction on heart failure outcomes:» JACC Heart Fail 2016 Jan: 4 (1): 24 heart failure outcomes:» JACC Heart Fail 2016 Jan: 4 (1): 24 Heart Fail 2016 Jan: 4 (1): 24 - 35.

The study sought to evaluate the impact of sodium restriction on heart failure outcomes.

CAD indicates coronary artery disease; CHF, congestive heart failure; CSM, clinically standardized meditation (a mantra meditation program); MA, meta - analysis; PA, primary analysis; PO, number of trials in which this was a primary outcome for the trial; and TM, transcendental meditation (a mantra meditation program).

«Higher proportions of palmitoleic acid in blood or adipose tissue are consistently associated with a myriad of undesirable outcomes, such as obesity,... inflammation, metabolic syndrome, type 2 diabetes, coronary disease, heart failure, and incidence and aggressiveness of prostate cancer,» the researchers wrote.

Secondary outcome The secondary outcome will be Psychological well - being of heart failure patients.